For Immediate Release

February 3, 2012

Sumitomo Chemical Reports
Consolidated Financial Results
For the Nine Months Ended December 31, 2011
The Sumitomo Chemical Group’s sales for the nine months ended December 31, 2011were ¥1,443.9 billion, a decrease of ¥22.6 billion compared with the same period of
the previous fiscal year. The Group’s operating income was ¥58.3 billion and ordinary
income was ¥48.5 billion, all representing year-on-year decreases. The Group
recorded a net loss of ¥11.3 billion, representing a decrease from the same period of
the previous fiscal year, because of large extraordinary losses in addition to thedecrease in ordinary income.
The Sumitomo Chemical Group’s financial results by business segment for thenine-month period were as follows.
Basic Chemicals
Despite higher market prices of methyl methacrylate and of raw materials used insynthetic fibers, sales declined due to a decrease in shipments as a result of theimpact of the earthquake and a decrease in demand. Consequently, the segment’ssales declined by ¥8.1 billion compared with the same period of the previous fiscal
year, to ¥215.6 billion, and operating income decreased by ¥6.0 billion, to ¥10.9billion.
Petrochemicals & Plastics
While shipments of synthetic resins and petrochemical products decreased as aresult of periodical maintenance shutdowns of manufacturing plants in Japan andabroad, in addition to the impact of the earthquake and a decrease in demand, sales
increased due to higher market prices overseas and higher selling prices in Japan inaccordance with a rise in prices of naphtha and other feedstocks. As a result, thesegment’s sales increased by ¥13.8 billion compared with the same period of theprevious fiscal year, to ¥491.6 billion, but operating income decreased by ¥3.7 billion,
to ¥6.3 billion.
IT-related Chemicals
Shipments of polarizing film used in liquid crystal displays (LCDs) increased due tohigher demand for use in smartphones and tablet PCs and because of an expansionof production capacity in Taiwan, but shipments of color filters decreased. In addition
to lower sales prices of both polarizing film and color filters, the value of sales ofoverseas subsidiaries decreased in yen terms due to the effects of a stronger yen. Asa result, the segment’s sales decreased by ¥26.5 billion compared with the same
period of the previous fiscal year, to ¥221.1 billion, and operating income decreasedby ¥14.6 billion, to ¥11.3 billion.
Health & Crop Sciences
Sales of the feed additive methionine increased steadily. In the area of crop
protection chemicals, shipments of herbicides remained strong in overseas markets.
Despite the decrease in the value of sales of overseas subsidiaries in yen terms dueto the effects of a stronger yen, the segment’s sales increased by ¥11.7 billion
compared with the same period of the previous fiscal year, to ¥190.8 billion, andoperating income increased by ¥1.2 billion, to ¥17.5 billion.

Pharmaceuticals
The Sumitomo Chemical Group initiated US sales of Latuda® (atypical antipsychotic)
in February 2011. Sales of Avapro® (therapeutic agent for hypertension), Lonasen®
(atypical antipsychotic), and the new drugs Trerief® (therapeutic agent for
Parkinson’s disease) and Metgluco® (biguanide oral hypoglycemic) increased as aresult of continued sales promotion activities. Sales of Amlodin® (therapeutic agentfor hypertension and angina pectoris), however, decreased due to competition withgeneric drugs. In addition, the value of sales of overseas subsidiaries decreased inyen terms due to the effects of a stronger yen. As a result, the segment’s sales
decreased by ¥16.9 billion compared with the same period of the previous fiscal year,to ¥287.8 billion, and operating income decreased by ¥3.1 billion, to ¥23.2 billion.
OthersIn addition to the above five segments, the Sumitomo Chemical Group engages insupplying electrical power and steam, providing services for the design, engineering,and construction management of chemical plants, providing transport andwarehousing, and conducting materials and environmental analyses. The segment’s
sales increased by ¥3.4 billion compared with the same period of the previous fiscal
year, to ¥37.0 billion, and operating income rose by ¥3.1 billion, to ¥4.8 billion.
(Note) Change in Reported Segments Classification Methods
As of April 1, 2011, the Fine Chemicals Segment was eliminated, and functional materials,additives, and dyes that had been included in this segment were transferred to the Basic
Chemicals Segment. In addition, pharmaceutical chemicals, which had also been included in thissegment, were transferred to the Agricultural Chemicals Segment. Following this change, theAgricultural Chemicals Segment changed its name to the Health & Crop Sciences Segment. The
businesses of consolidated subsidiaries in the Pharmaceuticals Segment that had been includedin the Others Segment were transferred to the Pharmaceuticals Segment.

The Company has revised its consolidated financial forecast for the full year ending
March 31, 2012. The forecast has been revised downward to sales of ¥1,990.0 billion,operating income of ¥65.0 billion, ordinary income of ¥54.0 billion, and net income of¥0.
The Company has also revised its projected year-end dividend from ¥6 per share to¥3 per share. As a result, the Company's projected dividend will be ¥9 per share on afull-year basis, the same level as for Fiscal 2010.
For further details, please refer to today’s release titled “Sumitomo ChemicalAnnounces Revisions to its Consolidated Financial Forecast and Projected Dividendfor Fiscal 2011.”

Summary of Consolidated Results(1) Results of Operations:

Net sales
Operating income
Ordinary income
Income before income taxes
and minority interests
Net (loss) income

Net (loss) income per 1,000 shares

Comprehensive income(2) Financial Position:
Total assets
Total net asset(3) Cash Flows:

Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Cash and cash equivalents at end of period(4) Results of Operations byBusiness Segment:
Net sales
Basic Chemicals
Petrochemicals & Plastics
IT-related Chemicals
Health & Crop Sciences
Pharmaceuticals
OthersOperating income
Basic Chemicals
Petrochemicals & Plastics
IT-related Chemicals
Health & Crop Sciences
Pharmaceuticals
OthersAdjustments

9 Months ended
December 31，2011*1
Yen （ Millions ）USD (Thousands)
1,443,924
18,573,759
58,349750,566
48,478623,591
16,940(11,337)

217,906(145,832)

Yen(6,936)

USD

Yen （ Millions ）(40,193)

9 Months ended
December 31，2010
Yen （ Millions ）1,466,554
79,26676,352
43,87014,135

*1

Yen
8,580

(89)
USD (Thousands)(517,018)*1

Yen （ Millions ）(34,196)

As of December 31, 2011*1
Yen （ Millions ）USD (Thousands)
2,289,007
29,444,392
694,987
8,939,889

As of March 31, 2011
Yen （ Millions ）2,367,314
758,886

9 Months ended
December 31，2011*1
Yen （ Millions ）USD (Thousands)
102,419
1,317,456(95,626)(1,230,075)(2,478)(31,875)
151,373
1,947,170

9 Months ended
December 31，2010
Yen （ Millions ）116,058(121,057)
31,072
140,503

9 Months ended
December 31，2011*1
Yen （ Millions ）USD (Thousands)

9 Months ended
December 31，2010
Yen （ Millions ） *2

215,641
491,576
221,061
190,819
287,827
37,0001,443,924

2,773,874
6,323,334
2,843,594
2,454,579
3,702,431
475,947
18,573,759

223,739
477,816
247,590
179,081304,705
33,623
1,466,554

10,873
6,284
11,332
17,47923,243
4,807(15,669)
58,349139,864
80,834
145,768
224,839
298,984
61,834(201,557)
750,566

16,8499,996
25,93016,313
26,321
1,730(17,873)
79,266(Note)*1:U.S. dollar amounts are translated from yen, for convenience only, at the rate of¥77.74= $1 prevailing on December 31, 2011.
*2:New business segmentation is applied to consolidated financial results of the previous fiscal year.